CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 27, 2005--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a developer of innovative pharmaceuticals for magnetic resonance imaging (MRI), today announced that it will release third quarter 2005 financial and operating results on Tuesday, November 1, 2005, before the open of regular market trading hours. A conference call to discuss these results and provide an update on regulatory matters, business development initiatives and commercial operations is scheduled for later that day, Tuesday, November 1, 2005, at 10:30 a.m. Eastern Time.
